Seeing is believing: Dietary fatty acids hurry up from the stomach to the heart of patients with impaired glucose tolerance

Diabetes

Volumn 61, Issue 11, 2012, Pages 2659-2660

  Iozzo, Patricia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FLUORODEOXYGLUCOSE F 18;

GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; NOTE; OBESITY; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

DIETARY FATS; FATTY ACIDS; FEMALE; GLUCOSE INTOLERANCE; HEART; HUMANS; LIPID METABOLISM; MALE; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84868033050     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0803     Document Type: Note

References (20)

1. Guzzardi MA, Iozzo P. Fatty heart, cardiac damage, and inflammation. Rev Diabet Stud 2011;8:403-417
2. Chiu HC, Kovacs A, Blanton RM, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005;96:225-233
3. Chiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001;107:813-822
4. Yagyu H, Chen G, Yokoyama M, et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 2003;111:419-426
5. Labbé SM, Grenier-Larouche T, Noll C, et al. Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans. Diabetes 2012;61:2701-2710
6. 18F]Fluoro-6-thia- heptadecanoic acid in rats. Mol Imaging Biol 2006;8:237-244
7. 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia. J Nucl Med 2007;48:455-462
8. Neitzel AS, Carley AN, Severson DL. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. Am J Physiol Endocrinol Metab 2003;284:E357-E365
9. Labbé SM, Croteau E, Grenier-Larouche T, et al. Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in type 2 diabetes. Diabetes 2011;60:408-415
10. Labbé SM, Grenier-Larouche T, Croteau E, et al. Organ-specific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography. Am J Physiol Endocrinol Metab 2011;300:E445-E453
11. Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004;109:2191-2196
12. Peterson LR, Soto PF, Herrero P, et al. Impact of gender on the myocardial metabolic response to obesity. JACC Cardiovasc Imaging 2008;1:424-433
13. Bucci M, Borra R, Någren K, et al. Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans. Cardiovasc Ther. 31 July 2011 [Epub ahead of print]
14. Bucci M, Borra R, Någren K, et al. Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities. Am J Physiol Endocrinol Metab 2011;301:E105-E112
15. Rijzewijk LJ, van der Meer RW, Lamb HJ, et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 2009;54:1524-1532
16. McGill JB, Peterson LR, Herrero P, et al. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance. J Nucl Cardiol 2011;18:421-429
17. Knuuti J, Takala TO, Någren K, et al. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia 2001;44:184-187
18. 18F]fluoro-6-thia- heptadecanoic acid. Diabetes 1999;48:1245-1250
19. Iozzo P, Turpeinen AK, Takala T, et al. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. J Clin Endocrinol Metab 2004;89:3496-3502
20. Lehto HR, Pärkkä J, Borra R, et al. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity, in relation with myocardial and muscle fat and adiponectin levels. J Clin Endocrinol Metab 2012;97:3277-3284